Fujian Cosunter Pharmaceutical Co Ltd Cash Flow Conversion Efficiency
Fujian Cosunter Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Fujian Cosunter Pharmaceutical Co Ltd (300436) has a cash flow conversion efficiency ratio of -0.055x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-25.74 Million ≈ $-3.77 Million USD) by net assets (CN¥468.48 Million ≈ $68.55 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
Cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. This chart illustrates how Fujian Cosunter Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Fujian Cosunter Pharmaceutical Co Ltd (300436) stock price for real-time trading data and today's change.
Fujian Cosunter Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained
Fujian Cosunter Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Fujian Cosunter Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Fujian Cosunter Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Fujian Cosunter Pharmaceutical Co Ltd worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Qingdao Sentury Tire Co Ltd
SHE:002984
|
0.014x |
|
HBX Group International plc
MC:HBX
|
-0.213x |
|
Grupo Lamosa S.A.B. de C.V
MX:LAMOSA
|
0.056x |
|
Compañía Cervecerías Unidas S.A
F:CVU
|
-0.006x |
|
Investec Ltd
JSE:INL
|
0.001x |
|
Genting Malaysia Bhd
KLSE:4715
|
0.065x |
|
A10 Network
NYSE:ATEN
|
0.122x |
|
Xinjiang Joinworld Co Ltd
SHG:600888
|
0.014x |
Annual Cash Flow Conversion Efficiency for Fujian Cosunter Pharmaceutical Co Ltd (2011–2025)
The table below shows the annual cash flow conversion efficiency of Fujian Cosunter Pharmaceutical Co Ltd from 2011 to 2025. Review Fujian Cosunter Pharmaceutical Co Ltd free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥346.30 Million ≈ $50.67 Million |
CN¥-35.05 Million ≈ $-5.13 Million |
-0.101x | -293.94% |
| 2024-12-31 | CN¥396.78 Million ≈ $58.06 Million |
CN¥20.71 Million ≈ $3.03 Million |
0.052x | +117.02% |
| 2023-12-31 | CN¥569.24 Million ≈ $83.30 Million |
CN¥-174.60 Million ≈ $-25.55 Million |
-0.307x | -144.91% |
| 2022-12-31 | CN¥955.62 Million ≈ $139.84 Million |
CN¥-119.68 Million ≈ $-17.51 Million |
-0.125x | -640.11% |
| 2021-12-31 | CN¥1.05 Billion ≈ $153.63 Million |
CN¥-17.76 Million ≈ $-2.60 Million |
-0.017x | -163.14% |
| 2020-12-31 | CN¥581.99 Million ≈ $85.16 Million |
CN¥15.60 Million ≈ $2.28 Million |
0.027x | -54.76% |
| 2019-12-31 | CN¥573.74 Million ≈ $83.96 Million |
CN¥33.99 Million ≈ $4.97 Million |
0.059x | +204.40% |
| 2018-12-31 | CN¥562.35 Million ≈ $82.29 Million |
CN¥10.94 Million ≈ $1.60 Million |
0.019x | -84.97% |
| 2017-12-31 | CN¥552.05 Million ≈ $80.78 Million |
CN¥71.47 Million ≈ $10.46 Million |
0.129x | -3.16% |
| 2016-12-31 | CN¥552.36 Million ≈ $80.83 Million |
CN¥73.84 Million ≈ $10.81 Million |
0.134x | -37.82% |
| 2015-12-31 | CN¥519.20 Million ≈ $75.97 Million |
CN¥111.63 Million ≈ $16.33 Million |
0.215x | -68.49% |
| 2014-12-31 | CN¥156.87 Million ≈ $22.96 Million |
CN¥107.04 Million ≈ $15.66 Million |
0.682x | +47.49% |
| 2013-12-31 | CN¥143.10 Million ≈ $20.94 Million |
CN¥66.20 Million ≈ $9.69 Million |
0.463x | +19.69% |
| 2012-12-31 | CN¥108.59 Million ≈ $15.89 Million |
CN¥41.97 Million ≈ $6.14 Million |
0.387x | -52.42% |
| 2011-12-31 | CN¥65.43 Million ≈ $9.58 Million |
CN¥53.15 Million ≈ $7.78 Million |
0.812x | -- |
About Fujian Cosunter Pharmaceutical Co Ltd
Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. The company offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men's health, and other fields. It also provides technical services such as drug development, including the deve… Read more